Role of lipid, apolipoprotein levels and apolipoprotein e genotype in young Italian patients with myocardial infarction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 3, 1999, Pages 118-124

  Scaglione, L ^a   Bergerone, S ^b   Gambino, R ^a   Imazio, M ^b   Macchia, G ^b   Cravetto, A ^b   Gaschino, G ^c   Baralis, G ^d   Rosettani, E ^b   Pagano, G ^a   Cassader, M ^a,e  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c MARIA VITTORIA HOSPITAL   (Italy)

^d Cardiology Division   (Italy)

^e Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN E; LIPID;

ADULT; ARTICLE; BLOOD; BODY MASS; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENETICS; GENOTYPE; HEART INFARCTION; HUMAN; ITALY; MALE; RISK FACTOR; SMOKING;

ADULT; APOLIPOPROTEINS; APOLIPOPROTEINS E; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; GENOTYPE; HUMANS; ITALY; LIPIDS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING;

EID: 0033145049     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lamm G (1981) The epidemiology of acute myocardial infarction in young age groups. In: Roskamm H (ed) Myocardial infarction at young age. Springer-Verlag, Berlin, pp 5-12
2. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI 2 (1990) A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 336: 65-71
3. Zimmerman FH, Cameron A, Fischer LD, Grace NG (1995) Myocardial infarction in Young Adults: Angiographic characterization, risk factor and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26: 654-661
4. Skinner JS, Albers CJ, Goudevenos J, Fraser C, Odemuyiwa, Hall RJ, Adams PC (1995) Prospective study of patients aged 55 years or less with acute myocardial infarction between 1981 and 1985: outcome 7 years and beyond. Br Heart J 74: 604-610
5. Malmberg K, Bavenholm P, Hamsten A (1994) Clinical and biochemical factors associated with prognosis after myocardial infarction at young age. J Am Coll Cardiol 24: 592-599
6. Hamsten A, Walldius G, Dahlen G, Johansson B, Faire U (1986) Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 59: 223-235
7. Wolfe MW, Vacek JL (1988) Myocardial infarction in the Young. Angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years. Chest 94: 926-930
8. Uhl GS, Farrel PW (1983) Myocardial infarction in young adults: risk factors and natural history. Am Heart J 105: 548-553
9. Glover MU, Kuber MT, Warren SE, Vieweg WVR (1982) Myocardial Infarction before age 36: risk factor and arteriographic analysis. Am J Cardiol 49: 1600-1603
10. Hoit BD, Gilpin EA, Henning H, Maisel AA, Dittrich H, Carlisle J, Ross J (1986) Myocardial infarction in young patients: an analysis by age subsets. Circulation 74: 712-721
11. Kanitz MG, Giovannucci SJ, Jones JS, Mott M (1996) Myocardial infarction in young adults: risk factors and clinical features. J Emerg Med 14: 139-145
12. Tornvall P, Bavenholm P, Landou C, de Faire U, Hamsten A (1993) Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary disease in young patients with myocardial infarction. Circulation 88: 2180-2189
13. Mahley RW, Innerarity TL (1983) Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737: 197-222
14. Brown MS, Goldstein JL (1985) The receptor model for transport of cholesterol in plasma. Ann NY Acad Sci 454: 178-182.
15. Utermann G, Hees M, Steinmetz A (1977) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 269: 604-607
16. Zannis VI, Just PW, Breslow JL (1981) Human apolipoprotein E subclasses are genetically determined. Am J Hum Genet 33: 11-24
17. Robertson FW, Cumming AM (1985) Effects of apoprotein E polymorphism on serum lipoprotein concentration. Arteriosclerosis 5: 283-292
18. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285
19. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, Amouyel P, Schaffer P, Ruidavets JP, Cambien F, Fruchart JC, Ducimetière P (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14: 1412-1419
20. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrel RE, Neaton JD (1993) Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71: 160-165
21. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 272: 1666-1671
22. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91: 265-269
23. Cumming AM, Robertson F (1984) Polymorphism at the apo E locus in relation to risk of coronary disease. Clin Genet 25: 310-313
24. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H (1986) Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 32: 778-781
25. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM (1996) Apolipoprotein E alleles and risk of coronary disease. Arterioscler Thromb Vasc Biol 16: 1250-1255
26. Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr (1997) Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Can J Cardiol 13: 253-260
27. Hixon JE (1991) Apolipoprotein E polymorphism affects atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 11: 1237-1244
28. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature: nomenclature and criteria for diagnosis of ischemic heart disease (1979) Circulation 59: 607-609
29. Joint National Committee on Detection (1993) Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 153: 154-183
30. Warnick GR, Albers JJ (1978) A comprehensive evolution of the heparin manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 29: 65-76
31. Friedewald WT, Levy RI, Frederickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
32. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 31: 545-548
33. Genest J, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, Wilson PWF, Salem DN, Schaefer EJ (1992) Lipoprotein cholesterol, apolipoprotein A-1 and B and lipoprotein(a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 19: 792-802
34. Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2-14
35. Assmann G, Schulte H, von Eckardstein A (1996) Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77: 1179-1184
36. Rader DJ, Hoeg JM, Brewer HB (1994) Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120: 1012-1025
37. Frazen J, Fex G (1986) Low serum apolipoprotein A-1 in acute myocardial infarction survivors with normal HDL cholesterol. Atherosclerosis 59: 37-42
38. Tikkanen M, Huttunen JK, Pajukanta PE, Pietinen P (1995) Apolipoprotein E polymorphism and dietary plasma cholesterol response. Can J Cardiol 11(Suppl G): 93G-96G
39. Ruiu G, Cassader M, Gambino R, Alemanno N, Demichieli F, Pagano A, Pagano G (1995) Apolipoprotein E allele frequencies in an Italian population: relation to age and lipid profile. Aging Clin Exp Res 7: 185-189
40. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ for te West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
41. Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. BMJ 291: 97-104